Hakutulokset - Goldin, Mark

Fragmented central venous catheter retained for years with minimal symptoms Tekijä Mullan, Clancy W., Tariq, Umair, Goldin, Mark

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Vascular thromboembolic events following COVID‐19 hospital discharge: Incidence and risk factors Tekijä Spyropoulos, Alex C., Giannis, Dimitrios, Goldin, Mark

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Complement-mediated microvascular injury and thrombosis in the pathogenesis of severe COVID-19: A review Tekijä Gianni, Panagiota, Goldin, Mark, Ngu, Sam, Zafeiropoulos, Stefanos, Geropoulos, Georgios, Giannis, Dimitrios

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Impact of recent guideline changes on aspirin prescribing after knee arthroplasty Tekijä Shah, Sarav S., Satin, Alexander M., Mullen, James R., Merwin, Sara, Goldin, Mark, Sgaglione, Nicholas A.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in China Tekijä Shang, Hong, Han, Xiaoxu, Shi, Xuanling, Zuo, Teng, Goldin, Mark, Chen, Dan, Han, Bing, Sun, Wei, Wu, Hao, Wang, Xinquan, Zhang, Linqi

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Comprehensive Analysis of Pathogen-specific Antibody Response in Vivo Based on an Antigen Library Displayed on Surface of Yeast Tekijä Zuo, Teng, Shi, Xuanling, Liu, Zhonghua, Guo, Linlin, Zhao, Qing, Guan, Tianxia, Pan, Xianming, Jia, Na, Cao, Wuchun, Zhou, Boping, Goldin, Mark, Zhang, Linqi

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Good practice statements for antithrombotic therapy in the management of COVID‐19: Guidance from the SSC of the ISTH Tekijä Spyropoulos, Alex C., Connors, Jean M., Douketis, James D., Goldin, Mark, Hunt, Beverley J., Kotila, Taiwo R., Lopes, Renato D., Schulman, Sam, the International Society on Thrombosis and Haemostasis

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19 Tekijä Giannis, Dimitrios, Barish, Matthew A., Goldin, Mark, Cohen, Stuart L., Kohn, Nina, Gianos, Eugenia, Chatterjee, Saurav, Lesser, Martin, Coppa, Kevin, Hirsch, Jamie S., McGinn, Thomas, Spyropoulos, Alex C.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19 Tekijä Spyropoulos, Alex C., Cohen, Stuart L., Gianos, Eugenia, Kohn, Nina, Giannis, Dimitrios, Chatterjee, Saurav, Goldin, Mark, Lesser, Marty, Coppa, Kevin, Hirsch, Jamie S., McGinn, Thomas, Barish, Matthew A.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients Tekijä Cohen, Stuart L., Gianos, Eugenia, Barish, Mathew A., Chatterjee, Saurav, Kohn, Nina, Lesser, Martin, Giannis, Dimitrios, Coppa, Kevin, Hirsch, Jamie S., McGinn, Thomas G., Goldin, Mark E., Spyropoulos, Alex C.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19 Tekijä Goldin, Mark, Lin, Stephanie K., Kohn, Nina, Qiu, Michael, Cohen, Stuart L., Barish, Matthew A., Gianos, Eugenia, Diaz, Anise, Richardson, Safiya, Giannis, Dimitrios, Chatterjee, Saurav, Coppa, Kevin, Hirsch, Jamie S., Ngu, Sam, Firoozan, Sheila, McGinn, Thomas, Spyropoulos, Alex C.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial Tekijä Spyropoulos, Alex C., Goldin, Mark, Ageno, Walter, Albers, Gregory W., Elliott, C. Gregory, Hiatt, William R., Halperin, Jonathan L., Maynard, Gregory, Steg, P. Gabriel, Weitz, Jeffrey I., Spiro, Theodore E., Lu, Wentao, Marsigliano, Jessica, Raskob, Gary E., Barnathan, Elliot S.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older Tekijä Ageno, Walter, Lopes, Renato D., Goldin, Mark, Yusen, Roger D., Albers, Gregory W., Elliott, Gregory C., Halperin, Jonathan L., Hiatt, William R., Maynard, Gregory, Steg, Philippe Gabriel, Weitz, Jeffrey I., Suh, Eunyoung, Lu, Wentao, Barnathan, Elliot S., Raskob, Gary E., Spyropoulos, Alex C.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The... Tekijä Spyropoulos, Alex C., Goldin, Mark, Giannis, Dimitrios, Diab, Wassim, Wang, Janice, Khanijo, Sameer, Mignatti, Andrea, Gianos, Eugenia, Cohen, Marc, Sharifova, Gulru, Lund, Jeet M., Tafur, Alfonso, Lewis, Paul A., Cohoon, Kevin P., Rahman, Husneara, Sison, Cristina P., Lesser, Martin L., Ochani, Kanta, Agrawal, Nirav, Hsia, Judith, Anderson, Victoria E., Bonaca, Marc, Halperin, Jonathan L., Weitz, Jeffrey I.

Hae kokoteksti Hae kokoteksti Hae kokoteksti

Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry Tekijä Giannis, Dimitrios, Allen, Steven L., Tsang, James, Flint, Sarah, Pinhasov, Tamir, Williams, Stephanie, Tan, Gary, Thakur, Richa, Leung, Christian, Snyder, Matthew, Bhatia, Chirag, Garrett, David, Cotte, Christina, Isaacs, Shelby, Gugerty, Emma, Davidson, Anne, Marder, Galina S., Schnitzer, Austin, Goldberg, Bradley, McGinn, Thomas, Davidson, Karina W., Barish, Matthew A., Qiu, Michael, Zhang, Meng, Goldin, Mark, Matsagkas, Miltiadis, Arnaoutoglou, Eleni, Spyropoulos, Alex C.

Hae kokoteksti Hae kokoteksti Hae kokoteksti